Allscripts Healthcare Solutions (MDRX) Receives New Coverage from Analysts at Evercore ISI

Analysts at Evercore ISI started coverage on shares of Allscripts Healthcare Solutions (NASDAQ:MDRX) in a note issued to investors on Thursday, The Fly reports. The brokerage set a $17.50 price target on the software maker’s stock. Evercore ISI’s price objective would suggest a potential upside of 14.38% from the stock’s previous close.

A number of other equities analysts also recently issued reports on the company. SunTrust Banks downgraded Allscripts Healthcare Solutions from a “buy” rating to a “hold” rating in a research report on Tuesday. They noted that the move was a valuation call. Zacks Investment Research downgraded Allscripts Healthcare Solutions from a “hold” rating to a “sell” rating in a research report on Friday, January 12th. Royal Bank of Canada set a $19.00 price objective on Allscripts Healthcare Solutions and gave the stock a “buy” rating in a research report on Thursday, January 11th. Maxim Group restated a “buy” rating and set a $20.00 price objective on shares of Allscripts Healthcare Solutions in a research report on Tuesday, January 9th. Finally, Cantor Fitzgerald restated a “buy” rating and set a $17.00 price objective on shares of Allscripts Healthcare Solutions in a research report on Monday, January 8th. Two research analysts have rated the stock with a sell rating, six have given a hold rating and eleven have assigned a buy rating to the company. Allscripts Healthcare Solutions has an average rating of “Hold” and a consensus price target of $15.66.

Shares of Allscripts Healthcare Solutions (NASDAQ:MDRX) traded up $0.02 during mid-day trading on Thursday, hitting $15.30. The stock had a trading volume of 1,166,200 shares, compared to its average volume of 1,966,991. Allscripts Healthcare Solutions has a 12-month low of $11.01 and a 12-month high of $16.13. The firm has a market capitalization of $2,750.00, a price-to-earnings ratio of -13.19, a price-to-earnings-growth ratio of 2.16 and a beta of 1.32. The company has a quick ratio of 0.98, a current ratio of 0.98 and a debt-to-equity ratio of 1.20.

Allscripts Healthcare Solutions (NASDAQ:MDRX) last announced its quarterly earnings results on Thursday, November 2nd. The software maker reported $0.12 EPS for the quarter, meeting the Zacks’ consensus estimate of $0.12. Allscripts Healthcare Solutions had a positive return on equity of 6.53% and a negative net margin of 12.23%. analysts forecast that Allscripts Healthcare Solutions will post 0.46 EPS for the current year.

In other Allscripts Healthcare Solutions news, President Richard J. Poulton sold 15,000 shares of Allscripts Healthcare Solutions stock in a transaction that occurred on Friday, December 15th. The stock was sold at an average price of $14.26, for a total value of $213,900.00. Following the completion of the sale, the president now directly owns 1,351,773 shares in the company, valued at $19,276,282.98. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, SVP James Hewitt sold 36,796 shares of Allscripts Healthcare Solutions stock in a transaction that occurred on Friday, December 1st. The stock was sold at an average price of $14.11, for a total value of $519,191.56. Following the completion of the sale, the senior vice president now owns 181,766 shares of the company’s stock, valued at $2,564,718.26. The disclosure for this sale can be found here. Over the last quarter, insiders sold 56,796 shares of company stock valued at $804,842. 0.75% of the stock is currently owned by corporate insiders.

A number of hedge funds have recently modified their holdings of MDRX. ETF Managers Group LLC bought a new stake in shares of Allscripts Healthcare Solutions during the second quarter valued at approximately $152,000. Shelton Capital Management bought a new stake in shares of Allscripts Healthcare Solutions during the second quarter valued at approximately $170,000. Sheaff Brock Investment Advisors LLC bought a new stake in shares of Allscripts Healthcare Solutions during the third quarter valued at approximately $174,000. Crossmark Global Holdings Inc. bought a new stake in shares of Allscripts Healthcare Solutions during the third quarter valued at approximately $187,000. Finally, Oakbrook Investments LLC bought a new stake in shares of Allscripts Healthcare Solutions during the fourth quarter valued at approximately $194,000.

TRADEMARK VIOLATION NOTICE: This article was originally posted by American Banking News and is the property of of American Banking News. If you are reading this article on another domain, it was stolen and republished in violation of United States and international copyright and trademark law. The original version of this article can be read at https://www.americanbankingnews.com/2018/01/18/allscripts-healthcare-solutions-mdrx-receives-new-coverage-from-analysts-at-evercore-isi.html.

Allscripts Healthcare Solutions Company Profile

Allscripts Healthcare Solutions, Inc (Allscripts) delivers information technology (IT) solutions and services to help healthcare organizations. The Company operates through three segments: Clinical and Financial Solutions, Population Health, and Netsmart. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions.

The Fly

Analyst Recommendations for Allscripts Healthcare Solutions (NASDAQ:MDRX)

Leave a Reply